Zeiss Acquires Veracity Innovations, a Cataract Surgery Platform

By Staff
Wednesday, August 23, 2017 12:30 AM DUBLIN, Calif. and JENA, Germany—Zeiss has acquired Veracity Innovations, a medical software company in Temple, Texas. The purchase price was not disclosed.

Bascom Palmer Eye Institute Ranked First in Ophthalmology for 16th Time

By Staff
Wednesday, August 16, 2017 12:18 AM MIAMI—Bascom Palmer Eye Institute  of the University of Miami Health System and University of Miami Miller School of Medicine has again been ranked as the nation’s best in ophthalmology by U.S. News & World Report in its Best Hospitals edition.

Southern College of Optometry Opens Hybrid Clinic Featuring Telemedicine

By Staff
Friday, July 28, 2017 12:18 AM MEMPHIS, Tenn.—Southern College of Optometry is opening FocalPoint, the first facility of its kind in the U.S. to offer completely paperless telemedicine via EyecareLive.

Private-Equity Backed Eyeconic Vision Partners Acquires Phoenix Eyecare Group

By Staff
Monday, July 24, 2017 12:27 AM NEW YORK—Cortec Group, a private equity firm said that its portfolio company Eye Academy Holdings Inc. acquired Swagel-Wootton Hiatt Eye Center of Phoenix.

LSGPA Invests an Additional $500,000 in MacuLogix

By Staff
Friday, July 21, 2017 12:23 AM HARRISBURG, Pa.—The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) has invested an additional $500,000 in MacuLogix, a company that equips eyecare professionals with the instruments, tools and education needed to effectively manage patients with Age-related Macular Degeneration (AMD).

Second Sight Announces Expansion of Medicare Coverage for Argus II

By Staff
Monday, July 17, 2017 12:24 AM SYLMAR, Calif.—Second Sight Medical Products (NASDAQ:EYES) recently announced that its Argus II Retinal Prosthesis System can now be covered by Medicare in seven of the 12 Medicare Administrative Contractor (“MAC”) jurisdictions nationwide, representing a total of 28 states, two territories, and the District of Columbia.

Novaliq Names Gabriela Burian, MD, MPH as Chief Medical Officer

By Staff
Friday, June 30, 2017 12:15 AM HEIDELBERG, Germany—Novaliq GmbH, a Heidelberg-based specialty pharmaceutical company focused on ophthalmology, has appointed Gabriela Burian, MD, MPH, as chief medical officer. She will report to the company’s managing director and CEO, Christian Roesky, PhD.

Roger Valine Joins Grand Rapids Ophthalmology as Chairman

By Staff
Wednesday, June 28, 2017 12:27 AM GRAND RAPIDS, Mich.—Grand Rapids Ophthalmology (GRO) has appointed Roger J. Valine to its board of directors and he will serve as chairman.

Avedro Appoints Thomas E. Griffin as Chief Financial Officer

By Staff
Monday, June 26, 2017 12:21 AM WALTHAM, Mass.—Avedro, a Waltham, Mass.-based ophthalmic pharmaceutical and medical device company specializing in corneal remodeling, has appointed Thomas E. Griffin as chief financial officer.

Shire Names Snisarenko to Succeed Dempsey as Head of U.S. Ophthalmics Franchise

By Staff
Wednesday, June 21, 2017 12:15 AM LEXINGTON, Mass.—Shire announced this week that John Snisarenko has been named group vice president and head of ophthalmics U.S. franchise.

Johnson & Johnson Vision Names Jonathan Talamo as Chief Medical Officer

By Staff
Friday, June 9, 2017 12:27 AM NEW BRUNSWICK, N.J.—Johnson & Johnson Vision Care has named Dr. Jonathan Talamo as its new chief medical officer (CMO) and worldwide vice president of medical affairs and clinical affairs for Johnson & Johnson Vision, which comprises both its vision care and surgical businesses.

FDA Approves Nicox’s Zerviate, the First Topical Ocular Formulation of Antihistamine Cetirizine

By Staff
Monday, June 5, 2017 12:24 AM OPHIA ANTIPOLIS, France—Nicox S.A. (Euronext Paris: FR0013018124, COX), an ophthalmic research and discovery company, has announced that the Food and Drug Administration (FDA) has approved its new drug Zerviate (cetirizine ophthalmic solution 0.24%), the first topical ocular formulation of this antihistamine.

TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team

By Staff
Wednesday, May 31, 2017 12:23 AM ORANGE COUNTY, Calif.—TearClear Corp., an early-stage, eye health technology company, reported Tuesday that it completed a Series A financing round that generated proceeds of $4.5 million.

Dr. Brian Marr Named Director of Ophthalmic Oncology at NewYork-Presbyterian/Columbia Medical Center

By Staff
Wednesday, May 24, 2017 12:15 AM NEW YORK—Dr. Brian Marr will join the department of ophthalmology at NewYork-Presbyterian/Columbia University Medical Center as director of the division of ophthalmic oncology, effective May 15.

Georgia Governor Signs Legislation Authorizing ODs to Administer Some Injections

By Staff
Wednesday, May 17, 2017 12:27 AM ATLANTA—Georgia Gov. Nathan Deal last week signed legislation that will allow optometrists to perform certain types of injections in and around the eye.
Loading...